Chiesi Clinical Trial - Site 276459

Münster

0 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) — Stopped early